arsenic trioxide has been researched along with Adenocarcinoma of Lung in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Shen, Y; Zhang, R | 1 |
| Du, H; Li, B; Shi, XQ; Wang, MD; Yang, MH; Yin, JZ; Zhao, XW | 1 |
| Chang, WC; Chao, KSC; Cheng, WC; Cho, CF; Hsiao, TH; Hsu, JL; Huang, YK; Hung, MC; Kuo, TT; Lai, LC; Lee, PC; Lin, CC; Lin, YS; Liu, YH; Lo, CC; Sher, YP; Shih, JY; Sun, X; Tseng, GC | 1 |
| Chen, H; Gu, S; Lai, Y; Liu, Y; Zhang, Z | 1 |
| Chen, HY; Dai, HM; Gu, SY; Li, XY; Zhang, ZZ | 1 |
| Ho, JC; Kwong, YL; Lam, SK; Li, YY; Mak, JC; Zheng, CY | 1 |
| Ho, JC; Lam, SK; Leung, LL; Li, YY; Zheng, CY | 1 |
| Chen, C; Gu, S; Jiang, X; Zhang, Z | 2 |
| Chen, H; Dai, H; Gu, S; Li, X; Zhang, Z | 1 |
10 other study(ies) available for arsenic trioxide and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Animals; Arsenic Trioxide; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Mice; Prognosis | 2023 |
Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Animals; Arsenic Trioxide; Cell Line, Tumor; Humans; Lung Neoplasms; Macrophages; Mice; Signal Transduction; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression.
Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Membrane; Drug Resistance, Neoplasm; ErbB Receptors; Feedback, Physiological; Gene Expression Profiling; Gene Knockdown Techniques; Humans; Kaplan-Meier Estimate; Lung; Lung Neoplasms; Membrane Proteins; Mice; Mutation; Nerve Tissue Proteins; Prognosis; Protein Kinase Inhibitors; Proteolysis; Repressor Proteins; Signal Transduction; Tissue Array Analysis; Xenograft Model Antitumor Assays | 2020 |
miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; MicroRNAs; NF-E2-Related Factor 2; Signal Transduction | 2017 |
[miR-155/BACH1 Signaling Pathway in Human Lung Adenocarcinoma Cell Death Induced by Arsenic Trioxide].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Arsenic Trioxide; Arsenicals; Basic-Leucine Zipper Transcription Factors; Cell Death; Cell Line, Tumor; Heme Oxygenase-1; Humans; Lung Neoplasms; MicroRNAs; NAD(P)H Dehydrogenase (Quinone); Oxides; Signal Transduction | 2017 |
Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Mice, Nude; Oxides; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2014 |
E2F1 downregulation by arsenic trioxide in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Oxides; United States; United States Food and Drug Administration; Xenograft Model Antitumor Assays | 2014 |
ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Lung; Lung Neoplasms; Mitochondria; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
[Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Caspase 3; Drug Synergism; Glutathione; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Oxidation-Reduction; Oxides; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2016 |
Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Artemisinins; Bronchi; Cell Cycle Checkpoints; Cell Survival; DNA Damage; Epithelial Cells; Humans; Lung Neoplasms; Oxides; Reactive Oxygen Species | 2017 |